MedSwitcher
Medication Directory

Medication Directory

Browse medications across weight loss, ADHD, birth control, migraine, and more. Click any medication for detailed dosing, side effects, clinical trial results, and cost information.

Weight Loss

FDA-Approved Medications

Foundayo
FDA-Approved

orforglipron · Eli Lilly

Oral tablet
Once daily
$149/mo (lowest dose) to ~$349/mo (highest dose)

Weight loss: 12.4% (completers) / 11.2% (ITT) (ATTAIN-1 (17.2mg approved dose))

Ozempic
FDA-Approved

semaglutide · Novo Nordisk

Injectable pen (subcutaneous)
Once weekly
~$936/mo

Weight loss: ~15% (SUSTAIN 1-10 / STEP (off-label))

Wegovy (Injectable)
FDA-Approved

semaglutide · Novo Nordisk

Injectable pen (subcutaneous)
Once weekly
$199/mo introductory (0.25mg pen, until Aug 31, 2026) to ~$1,349/mo (list)

Weight loss: ~14.9% (STEP 1)

Wegovy (Oral)
FDA-Approved

semaglutide (oral) · Novo Nordisk

Oral tablet
Once daily (morning, on empty stomach)
$149/mo for 1.5mg and 4mg doses. Higher dose pricing not yet publicly set.

Weight loss: ~16.6% (OASIS 4)

Zepbound
FDA-Approved

tirzepatide · Eli Lilly

Injectable pen (subcutaneous)
Once weekly
$499/mo flat (all doses) via LillyDirect

Weight loss: ~22.5% (SURMOUNT-1)

Mounjaro
FDA-Approved

tirzepatide · Eli Lilly

Injectable pen (subcutaneous)
Once weekly
$499/mo flat (all doses) via LillyDirect

Weight loss: ~9.5% (SURPASS-1)

Rybelsus
FDA-Approved

semaglutide (oral) · Novo Nordisk

Oral tablet
Once daily (morning, on empty stomach)
~$936/mo

Weight loss: ~4-5% (PIONEER trials)

Saxenda
FDA-Approved

liraglutide 3mg · Novo Nordisk

Injectable pen (subcutaneous)
Once daily
$1,349/mo

Weight loss: 8% (ITT) (SCALE Obesity and Prediabetes)

Compounded (Not FDA-Approved)

⚠️ Important: Compounded GLP-1 medications are not FDA-approved. Quality varies by pharmacy, and FDA enforcement is increasing. Consider transitioning to an FDA-approved alternative.

Compounded Semaglutide
Not FDA-Approved

semaglutide (compounded) · Various compounding pharmacies

$179-299/mo
Compounded Tirzepatide
Not FDA-Approved

tirzepatide (compounded) · Various compounding pharmacies

$199-399/mo

ADHD

Vyvanse
FDA-Approved

lisdexamfetamine · Takeda

Capsule or chewable tablet
Once daily (morning)
$200–$400/mo (brand); $30–$80/mo (generic)

Weight loss: ADHD-RS improvement: −18.6 points vs −5.2 placebo (Phase 3 Pediatric ADHD Trial)

Concerta
FDA-Approved

methylphenidate ER · Janssen

Extended-release tablet (OROS osmotic delivery)
Once daily (morning)
$150–$350/mo (brand); $30–$60/mo (generic)

Weight loss: ADHD-RS improvement: −17.4 points vs −5.8 placebo (OROS Methylphenidate Pivotal Trial (Pediatric))

Strattera
FDA-Approved

atomoxetine · Eli Lilly

Capsule
Once or twice daily
$150–$300/mo (brand); $15–$50/mo (generic)

Weight loss: ADHD-RS improvement: −16.1 points vs −6.3 placebo (Atomoxetine Pediatric ADHD Trial)

Qelbree
FDA-Approved

viloxazine ER · Supernus Pharmaceuticals

Extended-release capsule
Once daily (morning)
$300–$450/mo (brand); ~$100–$200/mo (generic)

Weight loss: ADHD-RS-5 improvement: −17.0 points vs −11.8 placebo (Phase 3 Pediatric ADHD Trial (P301))

Birth Control

Yaz
FDA-Approved

drospirenone/ethinyl estradiol · Bayer

Oral tablet (24 active + 4 inactive, 28-day pack)
Once daily
$15–$40/mo (generic); $80–$120/mo (brand)

Weight loss: Pearl Index: 1.41 per 100 woman-years (typical use) (Yaz Contraceptive Efficacy Trial)

Lo Loestrin Fe
FDA-Approved

norethindrone acetate/ethinyl estradiol/ferrous fumarate · Allergan (AbbVie)

Oral tablet (26/2 regimen: 24 active + 2 EE-only + 2 iron)
Once daily
$80–$180/mo

Weight loss: Pearl Index: 2.98 per 100 woman-years (typical use) (Lo Loestrin Fe Contraceptive Efficacy Trial)

Opill
FDA-Approved

norgestrel · Perrigo

Oral tablet (continuous daily, no placebo pills)
Once daily at the same time each day
$19.99–$49.99/mo

Weight loss: Pearl Index: 2.0 per 100 woman-years (typical OTC use) (Opill OTC Actual-Use Study)

Mirena
FDA-Approved

levonorgestrel 52mg intrauterine system · Bayer

Intrauterine device (IUD) — T-shaped, inserted by healthcare provider
Replaced every 5 years (data supports up to 8 years)
$500–$1,300 (one-time insertion cost)

Weight loss: Pearl Index: 0.1 per 100 woman-years (Mirena Contraceptive Efficacy Study)

Migraine

Nurtec ODT
FDA-Approved

rimegepant · Pfizer/Biohaven

Orally disintegrating tablet (dissolves on tongue, no water needed)
As needed for acute attacks (max 1 per day) or every other day for prevention
$900–$1,100/mo (preventive use)

Weight loss: Pain freedom at 2 hours: 21.2% vs 10.9% placebo; MBS freedom: 35.1% vs 26.8% placebo (Phase 3 Acute Treatment Trial (Study 301))

Aimovig
FDA-Approved

erenumab-aooe · Amgen/Novartis

Subcutaneous injection (SureClick autoinjector)
Once monthly
$600–$700/mo

Weight loss: MMD reduction: −3.7 days vs placebo; ≥50% responder rate: 50.0% (140mg) (STRIVE (Episodic Migraine Prevention))

Don't miss price changes

GLP-1 prices are changing — stay ahead

Foundayo prices may increase — get alerts before they do. Track price drops, shortages, and new switching guidance without checking back manually.

  • Price increase warnings before they hit
  • Savings card and coupon alerts
  • New switching guidance and availability updates

No spam. Unsubscribe anytime. We never share your email.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. All clinical data referenced comes from published clinical trials and FDA prescribing information. Always consult your healthcare provider before starting, stopping, or switching any medication. Individual results may vary.